-Based Compensation

In March 2006, the Company's Board of Directors approved the Steven Madden, Ltd. 2006 Stock Incentive Plan, as amended (the “Plan”), under which nonqualified stock options, stock appreciation rights, performance shares, restricted stock, other stock-based awards, and performance-based cash awards may be granted to employees, consultants and non-employee directors. The following table summarizes the number of shares of common stock authorized for use under the Plan, the number of stock-based awards granted (net of expired or cancelled awards) under the Plan and the number of shares of common stock available for the grant of stock-based awards under the Plan:

Note J – Equity-Based Compensation (continued)



Common stock authorized	23,466,000
Stock-based awards, including restricted stock and stock options granted, net of expired or cancelled	(22,311,000	)
Common stock available for grant of stock-based awards as of March 31, 2018	1,155,000

Total equity-based compensation for the three months ended March 31, 2018 and 2017 is as follows:



	Three Months Ended March 31,
	2018		2017
Restricted stock	$	3,926	$	4,214
Stock options	967		962
Total	$	4,893	$	5,176

Equity-based compensation is included in operating expenses on the Company’s condensed consolidated statements of income.

Stock Options

Cash proceeds and intrinsic values related to total stock options exercised during the three months ended March 31, 2018 and 2017 are as follows:



	Three Months Ended March 31,
	2018		2017
Proceeds from stock options exercised	$	1,519	$	1,812
Intrinsic value of stock options exercised	$	576	$	1,011

During the three months ended March 31, 2018, options to purchase approximately 324,352 shares of common stock with a weighted average exercise price of $36.60 vested. During the three months ended March 31, 2017, options to purchase approximately 231,837 shares of common stock with a weighted average exercise price of $32.65 vested. As of March 31, 2018, there were unvested options relating to 1,114,716 shares of common stock outstanding with a total of $9,588 of unrecognized compensation cost and an average vesting period of 3.2 years.

The Company uses the Black-Scholes option-pricing model to estimate the fair value of options granted, which requires several assumptions. The expected term of the options represents the estimated period of time until exercise and is based on the historical experience of similar awards. Expected volatility is based on the historical volatility of the Company’s common stock. The risk

free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The dividend yield is based on the Company's annualized dividend per share amount divided by the Company's stock price. The following weighted average assumptions were used for stock options granted during the three months ended March 31, 2018 and 2017:

Note J – Equity-Based Compensation (continued)



	2018	2017
Volatility	26.0% to 26.3%	23.2% to 26.4%
Risk free interest rate	2.13% to 2.53%	1.48% to 1.99%
Expected life in years	3.8 to 4.4	3.4 to 5.0
Dividend yield	1.75%	0.00%
Weighted average fair value	$9.22	$8.97

Activity relating to stock options granted under the Company’s plans and outside the plans during the three months ended March 31, 2018 is as follows:



	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at January 1, 2018	1,899,000		$	35.80
Granted	210,000		44.30
Exercised	(47,000	)	32.43
Forfeited	(14,000	)	33.72
Outstanding at March 31, 2018	2,048,000		$	36.77	4.9 years	$	14,606
Exercisable at March 31, 2018	933,000		$	34.75	3.6 years	$	8,534

Restricted Stock

The following table summarizes restricted stock activity during the three months ended March 31, 2018 and 2017:



	2018				2017
	Number of Shares		Weighted Average Fair Value at Grant Date		Number of Shares		Weighted Average Fair Value at Grant Date
Non-vested at January 1,	3,916,000		$	26.05	4,191,000		$	25.93
Granted	160,000		45.37		166,000		36.61
Vested	(120,000	)	34.52		(125,000	)	33.15
Forfeited	(6,000	)	37.65		(3,000	)	34.77
Non-vested at March 31,	3,950,000		$	26.56	4,229,000		$	26.13

As of March 31, 2018, the Company had $66,243 of total unrecognized compensation cost related to restricted stock awards granted under the Plan. This cost is expected to be recognized over a weighted average of 5.2 years. The Company determines the fair value of its restricted stock awards based on the market price of its common stock on the date of grant.

Note J – Equity-Based Compensation (continued)

On January 3, 2012, the Company and its Creative and Design Chief, Steven Madden, entered into an amendment of Mr. Madden’s existing employment agreement, pursuant to which, on February 8, 2012, Mr. Madden was granted 1,463,057 restricted shares of the Company’s common stock at the then market price of $27.34, which vest in equal annual installments over a seven-year period commencing on December 31, 2017 and, thereafter, on each December 31 through December 31, 2023, subject to Mr. Madden’s continued employment on each such vesting date. On June 30, 2012, Mr. Madden exercised his right under his employment agreement to receive an additional restricted stock award, and, on July 3, 2012, he was granted 1,893,342 restricted shares of the Company's common stock at the then market price of $21.13, which vest in the same manner as the aforementioned grant. On August 8, 2016, pursuant to the employment agreement, Mr. Madden was granted an option to purchase 150,000 shares of the Company's common stock at an exercise price of $34.42 per share, which option was fully exercisable by November 8, 2017. On July 20, 2017, pursuant to his employment agreement, Mr. Madden was granted an option to purchase 150,000 shares of the Company's common stock at an exercise price of $40.15 per share, which option is exercisable in equal quarterly installments commencing on October 20, 2017. On March 1, 2017, pursuant to his employment agreement, Mr. Madden was granted an option to purchase 750,000 shares of the Company’s common stock at an exercise price of $37.35 per share, which option is exercisable in equal annual installments over a five-year period commencing on the first anniversary of the grant date. As of March 31, 2018, 600,000 shares remain unvested.